Given the following molecule represented by the SMILES string: COc1ccc(-c2csc(Cc3nc([O-])cs3)n2)cc1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The given molecule has a complex structure containing a benzene ring (indicated by the 'c' characters) with various substituents such as cyclohexane, thiophene, and an oxygen-containing functional group. This structure suggests the molecule may have a pharmacological activity, particularly due to its ability to interact with receptors and enzymes.
Step 2: Considering the presence of a benzene ring with attached functional groups, this molecule likely interacts with proteins involved in signal transduction pathways and drug metabolism. This interaction could be through binding to G-protein coupled receptors (GPCRs) or enzymes like cytochrome P450s (CYPs).
Step 3: The pattern of substituents, especially the thiophene and oxygen-containing functionalities, suggests potential interactions with GPCRs, which are known to have specific binding sites for ligands that contain aromatic rings and polar groups. Therefore, the molecule might interact with genes encoding GPCRs such as DRD2, DRD3, and DRD4, which are associated with dopamine signaling.
Step 4: Additionally, the presence of oxygen-containing groups indicates possible interactions with enzymes involved in phase I metabolism, such as CYP2C9, CYP2C19, and CYP2D6, which are known to metabolize drugs containing hydroxyl or other polar functional groups.
Step 5: Based on the above analysis, the molecule is most likely related to the following genes: DRD2, DRD3, DRD4, CYP2C9, CYP2C19, and CYP2D6. These genes encode proteins that are involved in neurotransmitter signaling and drug metabolism, respectively. 
Summary of related gene names:
- DRD2
- DRD3
- DRD4
- CYP2C9
- CYP2C19
- CYP2D6 Step 1: The molecule contains a benzene ring with multiple substituents, indicating potential interactions with biological targets.
Step 2: The presence of aromatic rings and polar functional groups suggests interactions with G-protein coupled receptors (GPCRs).
Step 3: Specific GPCR-related genes like DRD2, DRD3, and DRD4 are likely to be affected due to the pattern of substituents.
Step 4: Oxygen-containing functional groups suggest potential interactions with cytochrome P450 enzymes (CYPs), particularly CYP2C9, CYP2C19, and CYP2D6.
Step 5: Related gene names include: DRD2, DRD3, DRD4, CYP2C9, CYP2C19, and CYP2D6. 
- CYP2D6 Step 1: The molecule contains a benzene ring with various substituents, suggesting it may interact with biological targets.
Step 2: The presence of a thiophene ring and oxygen-containing groups indicates potential interactions with G-protein coupled receptors (GPCRs).
Step 3: Specific GPCR-related genes like DRD2, DRD3, and DRD4 are likely to be affected due to the molecular structure.
Step 4: The
